Are Nanoparticles the Future of PD Drug Delivery?
PDF-funded researcher James Dahlman Ph.D., of the Georgia Institute of Technology is looking for ways to deliver genetic therapies for PD using tiny chemical structures called nanoparticles.Learn More
What's New in Research?
What's new in PD research and treatment? In this report, James Beck, Ph.D., VP, Scientific Affairs discusses recent trends and discoveries.
Diagnosis PD, Now What? Managing the First Few Years with Parkinson’s
Tuesday, March 7 (Online)
There are many things a person can do early on to take charge and set a strong foundation for a journey with Parkinson's disease. Learn more by joining a one-hour PDF online seminar led by Suketu Khandhar, M.D., Medical Director, Kaiser Permanente Northern California Movement Disorders Program, Kaiser Permanente Sacramento Medical Center.
Parkinson’s Foundation Appoints John L. Lehr as Chief Executive Officer
January 10, 2017
The Board of Directors of the Parkinson’s Foundation today announced its selection of John L. Lehr, a noted nonprofit leader, as chief executive officer. The hiring follows the recent merger of two Parkinson’s nonprofits with rich histories: National Parkinson Foundation, headquartered in Miami, and Parkinson’s Disease Foundation, headquartered in New York. Lehr brings to the Parkinson’s Foundation more than two decades of nonprofit fundraising and management experience.